U.S. Tech Hardware Stock News

NasdaqGS:APLS
NasdaqGS:APLSBiotechs

Apellis Pharmaceuticals (APLS) Profitability Shift Tests Bullish Narratives After Q4 Loss

Apellis Pharmaceuticals (APLS) capped FY 2025 with Q4 revenue of US$199.9 million and basic EPS of US$0.47 loss, alongside a net loss of US$59.0 million. On a trailing twelve month basis, the company booked revenue of US$1.0 billion and basic EPS of US$0.18 profit. Over the past year, revenue has moved from US$781.4 million to US$1.0 billion on a trailing basis, with EPS shifting from a loss of US$1.60 to a profit of US$0.18. This sets up a story where investors may weigh sustained revenue...
NYSE:HVT
NYSE:HVTSpecialty Retail

Haverty Furniture Companies Q4 EPS Beat Challenges Long Term Earnings Decline Narrative

Haverty Furniture Companies posts steady FY 2025 finish with higher Q4 earnings Haverty Furniture Companies (HVT) has wrapped up FY 2025 with Q4 revenue of US$201.9 million and basic EPS of US$0.52, alongside net income of US$8.5 million, setting a clear marker for how the year closed. The company has seen quarterly revenue move from US$175.9 million in Q3 FY 2024 to US$201.9 million in Q4 FY 2025, while basic EPS shifted from US$0.30 to US$0.52 over the same stretch, giving investors a...
NasdaqGS:HSTM
NasdaqGS:HSTMHealthcare Services

HealthStream (HSTM) Margin Compression Challenges Bullish Earnings Growth Narrative

HealthStream (HSTM) closed out FY 2025 with Q4 revenue of US$79.7 million and basic EPS of US$0.09, alongside trailing 12 month revenue of US$304.1 million and EPS of US$0.61 that frame the latest quarter in a broader earnings context. Over recent periods, the company has seen revenue move from US$291.6 million on a trailing basis after Q4 2024 to US$304.1 million after Q4 2025, while trailing EPS shifted from US$0.66 to US$0.61, setting up a picture where earnings forecasts and valuation...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Erie Indemnity (ERIE) Margin Compression Challenges Long Term Earnings Growth Narrative

Erie Indemnity (ERIE) closed out FY 2025 with fourth quarter revenue of US$951.0 million and basic EPS of US$1.21, while trailing twelve month revenue stood at about US$4.1 billion and EPS at US$10.70. Together, these figures set the scene for a year in which margins and earnings quality will be front of mind for investors. The company has seen quarterly revenue move from US$924.1 million and EPS of US$3.29 in Q4 2024 to US$951.0 million and EPS of US$1.21 in Q4 2025. Those shifts, alongside...
NYSE:RXO
NYSE:RXOTransportation

Is RXO (RXO) Pricing Reflecting Recent Share Weakness And DCF Upside Potential

If you are trying to figure out whether RXO is attractively priced right now, it helps to separate the share price story from the underlying valuation story. RXO closed at US$14.84 recently, with a small 0.1% move over the last week, a 4.6% decline over the past month, a 15.6% gain year to date, and a 25.5% decline over the past year. Recent price moves have put RXO back on the radar as investors reassess transportation and logistics names in light of sector specific news flow and changing...
NasdaqGS:DHC
NasdaqGS:DHCHealth Care REITs

DHC (DHC) Revenue Holds Near US$380 Million As Losses Reinforce Bearish Narratives

Diversified Healthcare Trust (DHC) closed FY 2025 with Q4 revenue of US$379.6 million and a basic EPS loss of US$0.09, while trailing twelve month revenue came in at about US$1.5 billion with a basic EPS loss of US$1.19. The company has seen quarterly revenue hold in a tight band between US$373.6 million and US$388.7 million from Q3 2024 through Q4 2025, alongside basic EPS results ranging from a US$0.04 loss to a US$0.68 loss per quarter. This sets the scene for investors to focus closely on...
NYSE:ACVA
NYSE:ACVACommercial Services

ACV Auctions Q4 Loss Of US$19.6m Tests Bullish Profitability Narrative

ACV Auctions (ACVA) has wrapped up FY 2025 with Q4 revenue of US$183.6 million and a basic EPS loss of US$0.11, while trailing twelve month revenue came in at US$759.6 million with a basic EPS loss of US$0.39. The company has seen revenue move from US$159.5 million in Q4 2024 to US$183.6 million in Q4 2025, with quarterly EPS losses ranging between US$0.04 and US$0.16 over the past six reported quarters. This sets the stage for investors to focus on how quickly those losses might narrow...
NasdaqGS:NOVT
NasdaqGS:NOVTElectronic

Novanta (NOVT) Margin Compression Challenges High Growth Narrative After FY 2025 Results

Novanta (NOVT) has wrapped up FY 2025 with fourth quarter revenue of US$258.3 million and basic EPS of US$0.46, alongside net income of US$17.5 million, setting the tone for how investors will read its latest earnings update. The company has seen quarterly revenue move from US$238.1 million and EPS of US$0.46 in Q4 2024 to US$258.3 million and EPS of US$0.46 in Q4 2025. Trailing twelve month net income of US$53.8 million on revenue of US$980.6 million provides the broader backdrop. With net...
NYSE:TPC
NYSE:TPCConstruction

Tutor Perini Recovery Highlights Stronger Cash Flow Margins And Execution Risks

Tutor Perini (NYSE:TPC) reports strong operational recovery with better cash flow and margin performance. The company posts a sharp improvement in quarterly EPS growth alongside healthier free cash flow. These operational shifts point to a business that is running more efficiently and generating stronger results from existing projects. Tutor Perini’s recent progress comes with the stock trading at $85.87, after a 4.4% gain over the past week and 13.0% over the past month. The move adds to a...
NasdaqGM:EVER
NasdaqGM:EVERInteractive Media and Services

EverQuote (EVER) Net Margin Surge Tests Views On Earnings Quality And Low P/E

EverQuote (EVER) just wrapped up FY 2025 with fourth quarter revenue of US$195.3 million and basic EPS of US$1.60, alongside net income of US$57.8 million, setting a clear headline for its latest results. The company has seen revenue move from US$147.5 million and EPS of US$0.35 in Q4 2024 to US$195.3 million and EPS of US$1.60 in Q4 2025, with trailing twelve month revenue at US$692.5 million and EPS at US$2.75 giving investors a fuller view of the earnings run rate. Taken together with a...
NYSE:BOW
NYSE:BOWInsurance

Bowhead Specialty Holdings (BOW) Combined Ratios In Mid 90s Reinforce Bullish Underwriting Narrative

Bowhead Specialty Holdings (BOW) just wrapped up FY 2025 with Q4 total revenue of US$151.7 million and basic EPS of US$0.40, alongside trailing 12 month revenue of US$551.6 million and EPS of US$1.59 that sit against a one year earnings increase of 40.6%. Over recent quarters the company has seen revenue move from US$119.3 million in Q4 2024 to US$151.7 million in Q4 2025, while basic EPS shifted from US$0.42 to US$0.40. This sets up a picture where margins and profit efficiency are firmly in...
NasdaqGS:UFPI
NasdaqGS:UFPIBuilding

UFP Industries (UFPI) Margin Squeeze In Q4 2025 Reinforces Bearish Profitability Narratives

UFP Industries (UFPI) has wrapped up FY 2025 with fourth quarter revenue of US$1.3 billion and EPS of US$0.70, while trailing 12 month figures show revenue of US$6.3 billion and EPS of US$5.00, giving investors a clear read on both the quarter and the year as a whole. Over recent quarters the company has seen revenue move from US$1.6 billion in Q1 2025 to US$1.8 billion in Q2 2025 and US$1.6 billion in Q3 2025 before landing at US$1.3 billion in Q4. EPS shifted from US$1.30 to US$1.70,...
NasdaqGM:RNAM
NasdaqGM:RNAMBiotechs

Avidity Biosciences (RNA) Posts FY 2025 US$237 Million Loss Challenging Bullish Growth Narratives

Avidity Biosciences (RNA) has wrapped up FY 2025 with fourth quarter revenue of about US$0.9 million, a basic EPS loss of US$1.54 and a net loss of roughly US$237.1 million. Over recent quarters the company has seen revenue move from US$2.3 million in Q3 2024 to US$12.5 million in Q3 2025. Basic EPS shifted from a loss of US$0.65 in Q3 2024 to a loss of US$1.27 in Q3 2025, and trailing 12 month EPS landed at a loss of US$4.97. This sets the stage for a results season where investors are...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

Brighthouse Financial (BHF) Margin Resilience Supports Bullish Narratives Despite EPS Volatility

Brighthouse Financial (BHF) closed out FY 2025 with Q4 revenue of US$1,689 million and basic EPS of US$1.94, alongside net income of US$112 million, setting a clear marker for how the year finished. Over recent quarters, the company has seen revenue move from US$2,373 million in Q1 2025 to US$860 million in Q2, US$1,808 million in Q3 and then US$1,689 million in Q4. Basic EPS swung from a loss of US$5.05 in Q1 to US$1.04 in Q2, US$7.92 in Q3 and US$1.94 in Q4, giving investors plenty to weigh...
NasdaqGS:FANG
NasdaqGS:FANGOil and Gas

Diamondback Energy (FANG) Margin Collapse Challenges Bullish Earnings Narratives

Latest FY 2025 Earnings Snapshot Diamondback Energy (FANG) has just closed out FY 2025 with Q4 revenue of US$3.8 billion and a basic EPS loss of US$5.08, compared with Q4 FY 2024 revenue of US$3.5 billion and basic EPS of US$3.67. Over the same period, trailing twelve month revenue moved from US$10.6 billion at the end of FY 2024 to US$14.9 billion at the end of FY 2025, while trailing EPS shifted from US$15.53 to US$5.73. With trailing net margin down from 31.4% to 11.1% and profits under...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Henry Schein (HSIC) Margin Stays Near 3% And Tests Premium P/E Narrative

Henry Schein (HSIC) has wrapped up FY 2025 with fourth quarter revenue of US$3.4 billion and basic EPS of US$0.86, alongside trailing twelve month revenue of US$13.2 billion and EPS of US$3.29 that frame the latest print in a broader context. The company has seen quarterly revenue move from US$3.2 billion in Q4 2024 to US$3.4 billion in Q4 2025, with basic EPS shifting from US$0.75 to US$0.86 over the same period. Trailing twelve month EPS moved from US$3.08 to US$3.29 as investors weigh...
NYSE:GNW
NYSE:GNWInsurance

Genworth Financial Q4 Loss And 3% Margin Pressure Reinforce Bearish Narratives

Genworth Financial (GNW) has wrapped up FY 2025 with Q4 revenue of US$1.8 billion and a basic EPS loss of US$0.05 from continuing operations, while trailing twelve month revenue sits at US$7.3 billion and EPS at US$0.54. Over recent periods the company has seen quarterly revenue move in a tight band between US$1.8 billion and US$1.9 billion, with basic EPS ranging from a loss of roughly US$0.05 in Q4 2025 to a profit of about US$0.30 in Q3 2025. This pattern is prompting investors to focus on...
NYSE:WH
NYSE:WHHospitality

Wyndham Debt Recast Raises Questions On Interest Costs And Flexibility

Wyndham Hotels & Resorts (NYSE:WH) has priced a planned issuance of US$650 million in Senior Notes due 2033. The company expects to use the proceeds to repay existing debt and for general corporate purposes. The new Senior Notes are guaranteed and will adjust Wyndham's overall debt structure once issued. Wyndham Hotels & Resorts, which franchises hotels across multiple brands, is raising fresh long term capital through this new bond issue. For you as an investor, this kind of refinancing...
NYSE:CTEV
NYSE:CTEVHealthcare Services

Claritev (CTEV) Q4 Loss Of US$4.88 EPS Reinforces Ongoing Unprofitability Narrative

Claritev (CTEV) has just wrapped up FY 2025 with Q4 revenue of US$246.6 million and a basic EPS loss of US$4.88, alongside trailing 12 month revenue of US$965.4 million and a basic EPS loss of US$17.30. Over recent quarters, the company has seen revenue move from US$230.5 million in Q3 2024 to US$246.6 million in Q4 2025. Quarterly basic EPS has ranged from a loss of US$24.25 in Q3 2024 to a loss of US$3.81 to US$4.88 through 2025, setting a backdrop of significant revenue scale paired with...
NYSE:BSM
NYSE:BSMOil and Gas

Black Stone Minerals (BSM) Net Margin Jumps To 67.5% Reinforcing Bullish Royalty Model Narrative

Black Stone Minerals (BSM) just wrapped up FY 2025 with fourth quarter revenue of US$90.5 million and basic EPS of US$0.31, alongside trailing twelve month revenue of US$401.0 million and EPS of US$1.28 that frame the latest print in a fuller context. Over the past year, the company has seen trailing twelve month revenue move from US$427.0 million and EPS of US$1.15 in Q4 2024 to US$401.0 million and US$1.28 respectively by Q4 2025, while net income on the same basis went from US$241.9...
NYSE:VMI
NYSE:VMIConstruction

Valmont Dividend Hike And New Director Shape Capital Allocation Story

Valmont Industries (NYSE:VMI) announced a 13% increase to its quarterly dividend. The company appointed Paul Maass, an experienced agribusiness executive, to its Board of Directors. Valmont Industries, known for its infrastructure and agricultural solutions, is drawing fresh attention with a higher dividend and a board appointment that speaks directly to its core markets. For income focused investors, the 13% dividend move highlights a fresh data point on capital returns policy. The...
NasdaqGS:MYGN
NasdaqGS:MYGNBiotechs

Myriad Genetics (MYGN) Quarterly Loss Narrows Yet Keeps Profitability Concerns In Focus

Myriad Genetics (MYGN) just closed FY 2025 with fourth quarter revenue of US$209.8 million and a quarterly loss of US$7.9 million, equivalent to basic EPS of a US$0.08 loss. Over recent periods the company has seen quarterly revenue move between US$195.9 million and US$213.1 million, while basic EPS has ranged from roughly breakeven in early FY 2025 to a much larger US$3.57 loss in the second quarter, reflecting a wide spread in earnings outcomes for shareholders. With trailing twelve month...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Is Pagaya (PGY) Turning Short-Term Guidance Volatility Into a Test of Its AI Underwriting Edge?

In recent weeks, Pagaya Technologies reported softer-than-expected first-quarter guidance but reiterated that it is seeing no operational slippage or credit stress, even as broader market volatility weighed on sentiment. Analysts have reaffirmed positive views on the company, arguing that its AI-driven underwriting platform and measured growth outlook remain intact despite short-term market noise. With analysts highlighting management’s reassurance about stable operations, we’ll now...
NYSE:PERF
NYSE:PERFSoftware

Perfect (PERF) Margin Compression Challenges Bullish High‑Growth Narrative After FY 2025 Results

Perfect (PERF) has just wrapped up FY 2025 with Q4 revenue of US$18.1 million and basic EPS of US$0.01, set against trailing twelve month revenue of US$69.2 million and EPS of US$0.05. Over recent quarters the company has seen revenue move from US$15.9 million in Q4 FY 2024 to US$18.1 million in Q4 FY 2025, while quarterly EPS has ranged between about US$0.002 and US$0.025 across FY 2025. This gives investors a clearer view of how growth and profitability are interacting. With a trailing net...